A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence. Results of a phase 3 ...
Source: Getty Images A new predictive model based on artificial intelligence identifies men who will and will not benefit from adding androgen deprivation therapy to radiation therapy for intermediate ...
Epidemiologic and experimental evidence suggests the effectiveness of androgen deprivation therapy (ADT) in prostate cancer (CaP) management. Although ADT has been increasingly used as mono-therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback